The most significant development this hour is President Xi Jinping’s directive for the People’s Liberation Army to accelerate the development of an intelligent military system, emphasizing AI and unmanned technologies to meet modernization targets by 2027. Elsewhere, the wire is dominated by routine regulatory churn, including numerous guidance updates from the FDA on biosimilars and drug delivery systems, as well as various FERC and CMS administrative notices. Beyond the federal activity, broader economic and social signals include BYD’s continued export-driven sales growth and promising results from a four-day school week pilot in Indiana, which reported improvements in attendance and academic performance.